APA (7th ed.) Citation

L, D., C, B., R, P., C, C., C, J., M, F., . . . C, C. (2025). Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 28, 15387. https://doi.org/10.3389/jpps.2025.15387

Chicago Style (17th ed.) Citation

L, Dubois, et al. "Compounding and Stability Studies of Liquid Oral Formulations of Beta-blockers (bisoprolol, Betaxolol, and Nadolol) for Paediatric Patients." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques 28 (2025): 15387. https://doi.org/10.3389/jpps.2025.15387.

MLA (9th ed.) Citation

L, Dubois, et al. "Compounding and Stability Studies of Liquid Oral Formulations of Beta-blockers (bisoprolol, Betaxolol, and Nadolol) for Paediatric Patients." Journal of Pharmacy & Pharmaceutical Sciences : A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, vol. 28, 2025, p. 15387, https://doi.org/10.3389/jpps.2025.15387.